# FDA recall D-0025-2016

> **Ohm Laboratories, Inc.** · Class III · drug recall initiated 2015-07-28.

## Product

Equaline Original Prescription Strength, loratadine orally disintegrating tablets, USP, 10 mg, packaged in a) 10-count tablets per box, NDC 41163-528-69, UPC 0 4116347138 2; and b) 30-count tablets per box, NDC 41163-528-31, UPC 0 4116346654 8; Distributed by: Supervalu Inc. Eden Prarie, MN  55344 USA

## Reason for recall

Superpotent Drug: Out Of Specification (OOS) result for Assay.

## Distribution

Nationwide.

## Key facts

- **Recall number:** D-0025-2016
- **Recalling firm:** Ohm Laboratories, Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2015-07-28
- **Report date:** 2015-10-21
- **Termination date:** 2016-10-28

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** North Brunswick, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0025-2016

## Citation

> AI Analytics. FDA recall D-0025-2016. Retrieved 2026-05-27 from https://api.ai-analytics.org/recall/D-0025-2016. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*